Page 209 - Personalised medicine of fluoropyrimidines using DPYD pharmacogenetics Carin Lunenburg
P. 209
SUPPLEMENT CHAPTER 7
Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers
Eur J Cancer. 2018;104:210-8
Carin A.T.C. Lunenburg, Linda M. Henricks, Eva Dreussi, Femke P. Peters, Marta Fiocco, Didier Meulendijks, Giuseppe Toffoli, Henk-Jan Guchelaar, Jesse J. Swen, Erika Cecchin, Jan H.M. Schellens, Hans Gelderblom
